Furthermore, RBM15 knockdown diminishes the activity of the TGF-β/Smad2 pathway, and pharmacological activation of TGF-β signaling with SRI-011381 reverses the inhibitory effect of RBM15 silencing on tumor cell growth (Feng et al., 2023). Here, TGFB1 is linked to neoplasm.